Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease

Nature Communications

Volumn 5, Issue , 2014, Pages

  Pujadas, Lluís ^a,b,c,d   Rossi, Daniela ^a,b,c   Andrés, Rosa ^a,b,c   Teixeira, Cátia M ^a,b,c   Serra Vidal, Bernat ^c   Parcerisas, Antoni ^a,b,c,d,e   Maldonado, Rafael ^f   Giralt, Ernest ^a,c   Carulla, Natàlia ^c   Soriano, Eduardo ^a,b,c,d,e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e Instituto de Salud Carlos III   (Spain)

^f UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; DOXYCYCLINE; REELIN; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); AMYLOID PRECURSOR PROTEIN; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; PEPTIDE FRAGMENT; PROTEIN BINDING; REELIN PROTEIN; SCLEROPROTEIN; SERINE PROTEINASE;

ADULT; BRAIN; MEMORY; NEUROLOGY; PATHOGENICITY; PATHOLOGY; PROTEIN; SIGNAL;

ADULT; ALZHEIMER DISEASE; AMNESIA; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITIC SPINE; HIPPOCAMPAL NEURONAL CULTURE; IMMUNOPRECIPITATION; MALE; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL BEHAVIOR; BRAIN; CELL CULTURE; DISEASE MODEL; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN; CELL ADHESION MOLECULES, NEURONAL; CELLS, CULTURED; COGNITION DISORDERS; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; HEK293 CELLS; HUMANS; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PLAQUE, AMYLOID; PROTEIN BINDING; SERINE ENDOPEPTIDASES;

EID: 84896788180     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4443     Document Type: Article

References (47)

1. Ballard, C. et al. Alzheimer's disease. Lancet 377, 1019-1031 (2011).
2. Querfurth, H. W. & LaFerla, F. M. Alzheimer's disease. New Engl. J. Med. 362, 329-344 (2010).
3. O'Brien, R. J. & Wong, P. C. Amyloid precursor protein processing and Alzheimer's disease. Annu. Rev. Neurosci. 34, 185-204 (2011).
4. Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112 (2007). (Pubitemid 46432529)
5. Mucke, L. & Selkoe, D. J. Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb. Perspect. Med. 2, a006338 (2012).
6. Lambert, M. P. et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448-6453 (1998).
7. Shankar, G. M. et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842 (2008).
8. Lesne, S. et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357 (2006).
9. Huang, Y. & Mucke, L. Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204-1222 (2012).
10. Karran, E., Mercken, M. & De Strooper, B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 10, 698-712 (2011).
11. Alcantara, S. et al. Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse. J. Neurosci. 18, 7779-7799 (1998). (Pubitemid 28441019)
12. Tissir, F. & Goffinet, A. M. Reelin and brain development. Nat. Rev. Neurosci. 4, 496-505 (2003). (Pubitemid 37280170)
13. Pujadas, L. et al. Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation. J. Neurosci. 30, 4636-4649 (2010).
14. Doehner, J., Madhusudan, A., Konietzko, U., Fritschy, J. M. & Knuesel, I. Co-localization of Reelin and proteolytic AbetaPP fragments in hippocampal plaques in aged wild-type mice. J. Alzheimers Dis. 19, 1339-1357 (2010).
15. Hoe, H. S., Tran, T. S., Matsuoka, Y., Howell, B. W. & Rebeck, G. W. DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing. J. Biol. Chem. 281, 35176-35185 (2006). (Pubitemid 46036557)
16. Ohkubo, N. et al. Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade. FASEB J. 17, 295-297 (2003).
17. Durakoglugil, M. S., Chen, Y., White, C. L., Kavalali, E. T. & Herz, J. Reelin signaling antagonizes beta-amyloid at the synapse. Proc. Natl Acad. Sci. USA 106, 15938-15943 (2009).
18. Baloyannis, S. J. Morphological and morphometric alterations of Cajal-Retzius cells in early cases of Alzheimer's disease: a Golgi and electron microscope study. Int. J. Neurosci. 115, 965-980 (2005). (Pubitemid 40934027)
19. Botella-Lopez, A. et al. Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc. Natl Acad. Sci. USA 103, 5573-5578 (2006).
20. Botella-Lopez, A. et al. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease. Neurobiol. Dis. 37, 682-691 (2010).
21. Chin, J. et al. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J. Neurosci. 27, 2727-2733 (2007). (Pubitemid 46438989)
22. Herring, A. et al. Reelin depletion is an early phenomenon of Alzheimer's pathology. J. Alzheimers Dis. 30, 963-979 (2012).
23. Kramer, P. L. et al. Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol. Aging 32, 2113-2122 (2011).
24. Seripa, D. et al. The RELN locus in Alzheimer's disease. J. Alzheimers Dis. 14, 335-344 (2008). (Pubitemid 352040050)
25. Kocherhans, S. et al. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice. J. Neurosci. 30, 9228-9240 (2010).
26. Mucke, L. et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050-4058 (2000). (Pubitemid 30365675)
27. Hiesberger, T. et al. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24, 481-489 (1999). (Pubitemid 29508421)
28. Howell, B. W., Herrick, T. M. & Cooper, J. A. Reelin-induced tyrosine [corrected] phosphorylation of disabled 1 during neuronal positioning. Genes Dev. 13, 643-648 (1999). (Pubitemid 29155970)
29. Bitan, G. & Teplow, D. B. Rapid photochemical cross-linking - a new tool for studies of metastable, amyloidogenic protein assemblies. Acc. Chem. Res. 37, 357-364 (2004).
30. Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489 (2003). (Pubitemid 36444329)
31. Shankar, G. M. & Walsh, D. M. Alzheimer's disease: synaptic dysfunction and Abeta. Mol. Neurodegener. 4, 48 (2009).
32. Moolman, D. L., Vitolo, O. V., Vonsattel, J. P. & Shelanski, M. L. Dendrite and dendritic spine alterations in Alzheimer models. J. Neurocytol. 33, 377-387 (2004). (Pubitemid 39361303)
33. Palop, J. J., Chin, J. & Mucke, L. A network dysfunction perspective on neurodegenerative diseases. Nature 443, 768-773 (2006). (Pubitemid 44622680)
34. Harris, J. A. et al. Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein. J. Neurosci. 30, 372-381 (2010).
35. Burke, S. N., Ryan, L. & Barnes, C. A. Characterizing cognitive aging of recognition memory and related processes in animal models and in humans. Front. Aging Neurosci. 4, 15 (2012).
36. Krstic, D., Pfister, S., Notter, T. & Knuesel, I. Decisive role of Reelin signaling during early stages of Alzheimer's disease. Neuroscience 246, 108-116 (2013).
37. Cohen, S. I. et al. Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism. Proc. Natl Acad. Sci. USA 110, 9758-9763 (2013).
38. Ghosh, P., Kumar, A., Datta, B. & Rangachari, V. Dynamics of protofibril elongation and association involved in Abeta42 peptide aggregation in Alzheimer's disease. BMC Bioinformatics 11(Suppl 6), S24 (2010).
39. Sanchez, L. et al. Abeta40 and Abeta42 amyloid fibrils exhibit distinct molecular recycling properties. J. Am. Chem. Soc. 133, 6505-6508 (2011).
40. Selkoe, D. J. Resolving controversies on the path to Alzheimer's therapeutics. Nat. Med. 17, 1060-1065 (2011).
41. Qiu, S., Zhao, L. F., Korwek, K. M. & Weeber, E. J. Differential reelin-induced enhancement of NMDA and AMPA receptor activity in the adult hippocampus. J. Neurosci. 26, 12943-12955 (2006). (Pubitemid 44954613)
42. Teixeira, C. M. et al. Cell-autonomous inactivation of the reelin pathway impairs adult neurogenesis in the hippocampus. J. Neurosci. 32, 12051-12065 (2012).
43. Knuesel, I. Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases. Prog. Neurobiol. 91, 257-274 (2010).
44. Forster, E. et al. Reelin, Disabled 1, and beta 1 integrins are required for the formation of the radial glial scaffold in the hippocampus. Proc. Natl Acad. Sci. USA 99, 13178-13183 (2002).
45. Nielsen, L. et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40, 6036-6046 (2001). (Pubitemid 32466306)
46. Fancy, D. A. & Kodadek, T. Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. Proc. Natl Acad. Sci. USA 96, 6020-6024 (1999). (Pubitemid 29256612)
47. Lambert, M. P. et al. Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J. Neurochem. 79, 595-605 (2001). (Pubitemid 33029933)